Top compounds associated with response to MCFD2


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K70511574 CTRPv2 pan-cancer AAC -0.17 3e-07
mRNA PX-12 CTRPv2 pan-cancer AAC -0.15 3e-07
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 4e-07
mRNA parbendazole CTRPv2 pan-cancer AAC -0.17 4e-07
mRNA WZ3105 GDSC1000 pan-cancer AAC -0.15 5e-07
mRNA YK 4-279 CTRPv2 pan-cancer AAC -0.17 7e-07
mRNA GSK461364 CTRPv2 pan-cancer AAC -0.16 8e-07
mRNA BI-2536 CTRPv2 pan-cancer AAC -0.16 9e-07
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.18 1e-06
mRNA BX-912 GDSC1000 pan-cancer AAC -0.15 1e-06
Download CSV